Article

Analysis of CD74 Occurrence in Oncogenic Fusion Proteins

2023-09-29

Abstract excerpt

CD74 is a type II cell surface receptor found to be highly expressed in several hematological and solid cancers, due to its ability to activate pathways associated with tumor cell survival and proliferation. Over the past 16 years, CD74 is emerging as a commonly detected fusion partner in multiple oncogenic fusion proteins. Studies have found CD74 fusion proteins in a range of cancers including lung adenocarcinoma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 449d0721-500d-509e-98df-ebf5bec2f94c
DOI: 10.20944/preprints202309.2000.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Analysis of CD74 Occurrence in Oncogenic Fusion ProteinsDOI 10.20944/preprints202309.2000.v1Read

Analysis of CD74 Occurrence in Oncogenic Fusion ProteinsSemantic proximity Read

Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid TumorsSemantic proximity Read

Analysis of the Coding Transcriptome in NSCLC Highlights Variant-Specific Gene Expression and Signaling in CD74-ROS1 FusionsSemantic proximity Read

Detection of NRG1 Gene Fusions in Solid TumorsSemantic proximity Read

Oncogenic gene fusions in cancer: from biology to therapySemantic proximity Read

<i>CD74–NRG1</i> Fusions in Lung AdenocarcinomaSemantic proximity Read

CD74 as a prognostic and M1 macrophage infiltration marker in a comprehensive pan-cancer analysisSemantic proximity Read

Clinically relevant fusion oncogenes: detection and practical implicationsSemantic proximity Read

RNA Sequencing Identifies Novel NRG1 Fusions in Solid Tumors that Lack Co-Occurring Oncogenic DriversSemantic proximity Read

Characterizing the molecular and clinical implications of NRG1 fusions in NSCLC through integrated RNA and DNA sequencing analysis.Semantic proximity Read

The emerging complexity of gene fusions in cancer.Semantic proximity Read

CD99 is a potential diagnostic and immunological biomarker in pan-cancerSemantic proximity Read